Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer.
Yee-Loi Louise WanPuja SapraJames BoltonJia Xin ChuaLindy G DurrantPeter L SternPublished in: Targeted oncology (2020)
These data support further investigation of A1mcMMAF in combination with platinum-based chemotherapy in ovarian and other cancer treatments.
Keyphrases
- cancer therapy
- papillary thyroid
- electronic health record
- squamous cell
- locally advanced
- big data
- phase ii study
- randomized controlled trial
- machine learning
- drug delivery
- lymph node metastasis
- artificial intelligence
- combination therapy
- phase iii
- rectal cancer
- deep learning
- study protocol
- double blind
- placebo controlled